Although the clinical application of TNF-α has been restricted because of its toxicity, the use of tumor-targeted therapeutic strategies employing nanoparticles or tumor-homing peptides offer great promise for the treatment of breast cancer. This evidence concerns the gene TNF and neoplasm.